Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 20/20 | 0.41 |
| ▸ | ITGA2B | P08514 | 20/20 | 0.41 |
| ▸ | ITGB2 | P05107 | 1/20 | 0.38 |
| ▸ | ITGAM | P11215 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9571124 | 0.91 | SMN1; SMN2 (0.40) | ITGB3ITGA2B | |
| SCHEMBL9245380 | 0.85 | ITGB3 (0.41) | ITGB3ITGA2BITGB2ITGAM | |
| SCHEMBL9254859 | 0.82 | ITGB3 (0.42) | ITGB3ITGA2BITGB2ITGAM | |
| SCHEMBL9255479 | 0.81 | ITGB3 (0.41) | ITGB3ITGA2BITGB2ITGAM | |
| SCHEMBL9255713 | 0.80 | ITGB3 (0.41) | ITGB3ITGA2BITGB2ITGAM | |
| SCHEMBL9251108 | 0.79 | ITGB3 (0.40) | ITGB3ITGA2BITGB2ITGAM | |
| SCHEMBL9247579 | 0.79 | ITGB3 (0.40) | ITGB3ITGA2BITGB2ITGAM | |
| SCHEMBL9251145 | 0.76 | MAPT (0.37) | ITGB3ITGA2B | |
| SCHEMBL9255921 | 0.76 | ITGB3 (0.40) | ITGB3ITGA2BITGB2ITGAM | |
| SCHEMBL9254738 | 0.76 | ITGB3 (0.41) | ITGB3ITGA2BITGB2ITGAM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5434150-A | Anticoagulants, cardiovascular disorders | DR. KARL THOMAE GMBH (DE) | 1995-07-18 | — | — | US | disclosed |
| EP-0531883-A1 | Condensed 5-membered ring heterocycles, process for their preparation and medicaments containing them | Dr. Karl Thomae GmbH (DE) | 1993-03-17 | — | — | EP | disclosed |